From Pharma Marketing Network Publishing

The new book from R.J. Lewis. Intelligence is free. Permission isn’t. Beyond Results: Pharmaceutical & Healthcare Marketing in the AI Age. Pre-Order Now.

THE NEW BOOK FROM R.J. LEWIS

Intelligence is free.
Permission isn’t.

Beyond Results book cover

Beyond ResultsPharmaceutical & Healthcare Marketing in the AI AgeBY R.J. LEWIS

Pre-Order Now

LATEST ARTICLES

Laptop displaying secure cloud data connections and healthcare analytics during a pharmaceutical marketing strategy meeting, illustrating media data neutrality.

Publicis Bought LiveRamp. Now Neutrality Is Part of the Product.

Publicis Groupe completed its acquisition of LiveRamp on November 2, 2026. Can shared marketing infrastructure remain neutral when one of the world's largest advertising...
Yutrepia patent settlement represented by a legal gavel, medication bottle, and laptop displaying HCP targeting, CRM workflows, and pharmaceutical marketing compliance controls.

A Patent Settlement Just Rewrote Liquidia’s Target List.

One patent settlement can make a pharmaceutical sales team's target list obsolete almost overnight. That is the overlooked story behind Liquidia's October 2026 agreement...
Healthcare provider discussing oral and injectable PrEP options with a patient to support informed HIV prevention decisions.

PrEP Marketing Has a New Job: Help Patients Choose, Not Just Know.

Knowing that HIV prevention exists is not the same as knowing which option fits someone's life. That's why helping patients understand their PrEP options...

Protected: R.J. Lewis’s New Book, Beyond Results: Pharmaceutical & Healthcare Marketing in the AI...

A decade after RESULTS, R.J. Lewis examines what AI really changes for pharma and healthcare marketing, and what it doesn't November 13, 2026: Beyond Results:...
Medicare drug pricing policy displayed alongside pharmaceutical vials, syringes, and medication packaging, illustrating changes to pharma formulation strategy.

CMS Just Made the “New Formulation” Playbook Less Valuable.

A new delivery method can give an established drug a fresh commercial story. Now, CMS is changing the rules. CMS's latest Medicare decision could...
Woman examining an autumn maple leaf with irregular edges and dark spots, symbolizing melanoma's ABCDE warning signs in BMS's fall awareness campaign.

Summer Was Over. BMS Launched the Melanoma Campaign Anyway.

Autumn leaves usually signal the end of summer. For Bristol Myers Squibb Canada, they became a reason to revisit skin health. Its November 2026...
Prescription drug bottles beside a declining TV advertising spending chart, with a baseball game on television and a streaming platform on a laptop.

Pharma TV Spending Dropped 14.5%. Baseball May Be Part of the Reason.

A 14.5% drop in prescription drug TV spending sounds like an industry retreat. But what if part of the decline came from a shorter...
Healthcare researcher reviewing telehealth patient data, treatment timelines, and clinical research analytics on a digital dashboard.

Ro Treats Patients. Now It Wants Their Care Journeys to Become Research.

A patient starts a GLP-1 medication online, reports side effects, and returns for follow-up care. Each interaction creates information about what treatment looks like...
Prescription app displaying ranked medications, patient ratings, and drug recommendations beside a judge's gavel, illustrating South Korea's DoctorNow advertising ruling.

The App Said “BEST Drugs.” The Court Said That Was Advertising.

Can a health app advertise a drug without showing an ad? South Korea's DoctorNow case shows why prescription app design deserves closer scrutiny. Its...
Conceptual image of a Voceryq immunotherapy vial, a glowing DNA helix, and a doctor discussing treatment with a patient, highlighting the challenges of communicating DNA medicine.

“DNA Medicine” Is a Breakthrough. It’s Also a Messaging Problem.

As Voceryq moves toward launch, DNA medicine commercialization faces a challenge that has little to do with the science: explaining what this unfamiliar treatment...
- Advertisement -